1H-Pyrazole, 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-
Anle138b
CAS: 882697-00-9
Molecular Formula: C16H11BrN2O2
1H-Pyrazole, 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)- - Names and Identifiers
1H-Pyrazole, 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)- - Physico-chemical Properties
| Molecular Formula | C16H11BrN2O2 |
| Molar Mass | 343.17 |
| Density | 1.567±0.06 g/cm3(Predicted) |
| Boling Point | 527.3±50.0 °C(Predicted) |
| Solubility | DMSO |
| Appearance | powder |
| Color | white to beige |
| pKa | 12.57±0.10(Predicted) |
| Storage Condition | 2-8°C |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. |
1H-Pyrazole, 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)- - Preparation solution concentration reference
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.914 ml | 14.57 ml | 29.14 ml |
| 5 mM | 0.583 ml | 2.914 ml | 5.828 ml |
| 10 mM | 0.291 ml | 1.457 ml | 2.914 ml |
| 5 mM | 0.058 ml | 0.291 ml | 0.583 ml |
Last Update：2024-01-02 23:10:35
1H-Pyrazole, 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)- - Reference Information
| biological activity | Anle138b is a novel oligomer modulator and aggregation inhibitor, formation of pathological aggregates of prion protein (PrP (SC)) and alpha-synuclein (alpha-syn) can be prevented. Anle138b had good oral bioavailability, blood brain barrier permeability and no toxicity was detected. Anle138b presents a new therapy for disease-modifying treatment in neurodegenerative diseases such as prion Virus, Parkinson's disease, etc. |
| Target | Value |
Last Update：2024-04-09 19:05:17
Supplier List
Spot supply
Product Name: Anle138b Visit Supplier Webpage Request for quotationCAS: 882697-00-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Spot supply
Product Name: Anle138b Visit Supplier Webpage Request for quotationCAS: 882697-00-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History